<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Patent Analysis Report: US 11,850,410 B2</title>
    <style>
        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            line-height: 1.6;
            margin: 0;
            padding: 0;
            background-color: #f8f9fa;
            color: #212529;
        }
        .container {
            width: 80%;
            margin: auto;
            overflow: hidden;
            padding: 20px 0;
        }
        header {
            background: #005A9C;
            color: #ffffff;
            padding: 20px 0;
            border-bottom: #003366 3px solid;
            text-align: center;
        }
        header h1 {
            margin: 0;
            font-size: 2.5em;
        }
        header p {
            margin-top: 5px;
            font-size: 1.1em;
        }
        .section {
            background: #ffffff;
            padding: 25px;
            margin-bottom: 20px;
            border-radius: 8px;
            box-shadow: 0 2px 5px rgba(0,0,0,0.1);
        }
        h2 {
            color: #005A9C;
            border-bottom: 2px solid #dee2e6;
            padding-bottom: 10px;
        }
        h3 {
            color: #343a40;
        }
        .highlight {
            background-color: #e9ecef;
            border-left: 5px solid #007bff;
            padding: 15px;
            margin: 20px 0;
            border-radius: 5px;
        }
        table {
            width: 100%;
            border-collapse: collapse;
            margin-top: 20px;
        }
        th, td {
            border: 1px solid #ddd;
            padding: 12px;
            text-align: left;
        }
        th {
            background-color: #f2f2f2;
            font-weight: bold;
        }
        ul, ol {
            padding-left: 20px;
        }
        li {
            margin-bottom: 10px;
        }
        .claim-element {
            font-family: 'Courier New', Courier, monospace;
            background-color: #f0f0f0;
            padding: 2px 5px;
            border-radius: 3px;
        }
        .opportunity {
            color: #28a745;
            font-weight: bold;
        }
        .risk {
            color: #dc3545;
            font-weight: bold;
        }
        footer {
            text-align: center;
            padding: 20px;
            margin-top: 20px;
            background: #343a40;
            color: #ffffff;
        }
    </style>
</head>
<body>

    <header>
        <h1>Patent Analysis &amp; Research Report</h1>
        <p>US 11,850,410 B2: Automatically Retracting Safety Needle Assembly</p>
    </header>

    <div class="container">
        <div class="section">
            <h2>1. Executive Summary</h2>
            <p>This patent details an automatically retracting safety needle assembly designed to solve a critical usability problem in prior art: the abrupt increase in resistive force required to activate the safety mechanism. The core innovation is a mechanism that ensures a <strong>substantially constant plunger force</strong> throughout the injection and activation sequence. This compels the user to complete the full dose before the needle automatically retracts, enhancing patient safety and ensuring dose accuracy. The invention achieves this through a clever interaction between a plunger-actuated <strong>Activation Fork (AF)</strong> and a spring-loaded <strong>Moving Sleeve (MOS)</strong>, which holds the syringe. Once the plunger reaches the end of its travel, the AF moves into a position that "un-gates" or releases the MOS, allowing a biasing element (spring) to retract the entire syringe and needle safely into the housing.</p>
        </div>

        <div class="section">
            <h2>2. Core Problem Solved & Novelty</h2>
            <div class="highlight">
                <p><strong>Primary Problem Solved:</strong> Conventional auto-retracting syringes often require the user to apply a significant final push (overcoming an "abrupt increase in resistive force") to trigger the retraction mechanism. An inexperienced user may mistake this resistance for the end of the injection, prematurely stop pushing, and fail to deliver the full dose and/or activate the safety feature.</p>
                <p><strong>Key Novelty & Highlight:</strong> The invention's primary inventive step is the elimination of this final resistance spike. As shown in the patent's comparison of FIG. 28 (prior art) vs. FIG. 29 (the invention), the force required by the user remains relatively flat until the very end of the plunger's travel. The retraction is triggered not by overcoming a force barrier, but by the plunger and Activation Fork reaching a specific *geometric position* that releases a pre-loaded spring. This makes the device more intuitive, reliable, and safe.</p>
            </div>
        </div>

        <div class="section">
            <h2>3. Structural Breakdown & Key Components</h2>
            <p>The assembly is a system of nested and interacting cylindrical components. The table below breaks down the main parts and their functions based on the First Embodiment (FIGS. 1-14) and Second Embodiment (FIGS. 15-27).</p>
            <table>
                <thead>
                    <tr>
                        <th>Component</th>
                        <th>Reference #(s)</th>
                        <th>Function</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>External Housing (EH)</strong></td>
                        <td>101, 201</td>
                        <td>The outermost shell that the user holds. Provides structural integrity, finger flanges (113, 213), and viewing windows (111, 211).</td>
                    </tr>
                    <tr>
                        <td><strong>Internal Housing (IH)</strong></td>
                        <td>102, 202</td>
                        <td>Fixed inside the EH. It acts as the primary guide and structural frame for the moving internal parts. It contains features like guiding ribs, protrusions, and a base wall for the spring to push against.</td>
                    </tr>
                    <tr>
                        <td><strong>Moving Sleeve (MOS)</strong></td>
                        <td>103 (ROS), 203 (LOS)</td>
                        <td>The core moving part that holds the syringe. It is biased proximally (towards the user) by the spring. It is held in a "ready" state by the Activation Fork. The patent shows two main versions: a <strong>Rotating Sleeve (ROS)</strong> and a <strong>Locking Sleeve (LOS)</strong>.</td>
                    </tr>
                    <tr>
                        <td><strong>Biasing Element (BE)</strong></td>
                        <td>104, 204</td>
                        <td>A compression spring that provides the energy for retraction. It is loaded between the stationary IH base wall and the flange wall of the MOS.</td>
                    </tr>
                    <tr>
                        <td><strong>Activation Fork (AF)</strong></td>
                        <td>105, 205</td>
                        <td>This is the "trigger" or "gatekeeper". It is coupled to the syringe plunger and moves distally (away from the user) with it. Its guiding arms (151, 251) physically block the MOS from retracting. At the end of the stroke, openings (252, 255) on the AF align with features on the MOS, allowing the MOS to move and initiate retraction.</td>
                    </tr>
                    <tr>
                        <td><strong>Syringe</strong></td>
                        <td>106, 206</td>
                        <td>A standard-type syringe with a barrel, plunger rod (161, 261), and needle (165, 265). It is coupled to and moves with the MOS.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="section">
            <h2>4. Mechanism of Action (Step-by-Step)</h2>
            <p>The operation can be understood in four key phases (based on the LOS embodiment, FIGS. 20-27):</p>
            <ol>
                <li><strong>Storage/Ready State:</strong> The spring (BE 204) is compressed, pushing on the Locking Sleeve (LOS 203). However, the LOS is prevented from moving proximally because its gripping snaps (232) are blocked from deflecting outward by the solid body of the Activation Fork's arms (251). The system is locked and ready for use.</li>
                <li><strong>Injection Phase:</strong> The user pushes the plunger rod (261). This simultaneously expels the medication and advances the attached Activation Fork (AF 205) distally. During this entire phase, the AF continues to block the LOS, and the resistive force felt by the user is simply the force required to push the fluid through the needle.</li>
                <li><strong>Activation (Geometric Trigger):</strong> As the plunger reaches the end of its travel, the Activation Fork (AF) has moved distally to a point where its pre-cut activation openings (252) are now perfectly aligned with the LOS gripping snaps (232). The AF is no longer blocking them.</li>
                <li><strong>Retraction & Locking Phase:</strong> The instant the LOS snaps are un-gated, the stored energy in the spring (BE 204) takes over. The spring pushes the LOS (and the attached syringe) proximally. The angled slopes (225) on the stationary IH cause the LOS snaps (232) to deflect outward through the now-aligned openings (252) in the AF, allowing the syringe to retract fully into the housing. Once retracted, other features on the LOS and IH engage to permanently lock the needle inside, preventing re-exposure and further movement.</li>
            </ol>
        </div>

        <div class="section">
            <h2>5. Opportunities for Improvement & New Design</h2>
            <p>This is a well-thought-out mechanical system, but there are always avenues for innovation.</p>
            <ul>
                <li><span class="opportunity">Component Simplification:</span> The assembly has a relatively high number of complex, molded parts (EH, IH, MOS, AF).
                    <ul>
                        <li><strong>Idea 1:</strong> Combine the Internal Housing (IH) and External Housing (EH) into a single, more complex molded part. This could reduce assembly steps and costs, at the expense of a more difficult mold.</li>
                        <li><strong>Idea 2:</strong> Integrate the Activation Fork (AF) directly into the plunger rod. Instead of a separate fork, the plunger rod itself could have the "gating" features (solid sections and openings) molded into its distal end. This would eliminate one part entirely.</li>
                    </ul>
                </li>
                <li><span class="opportunity">Material Innovation:</span>
                    <ul>
                        <li><strong>Idea 1:</strong> Explore self-lubricating polymers (e.g., PTFE-filled plastics) for the interacting surfaces of the AF and MOS. This could make the retraction even smoother and more reliable, especially after long-term storage.</li>
                        <li><strong>Idea 2:</strong> Investigate the use of a stored-energy elastomer instead of a metal compression spring. This could potentially reduce noise ("twang") upon activation and might offer a different force profile.</li>
                    </ul>
                </li>
                <li><span class="opportunity">User Interface & Ergonomics:</span>
                    <ul>
                        <li><strong>Idea 1:</strong> Enhance the end-of-dose indicator. In addition to the tactile "click" of retraction, incorporate a color-change indicator. For example, a colored element on the LOS could become visible through a window in the housing only after retraction is complete.</li>
                        <li><strong>Idea 2:</strong> The design uses standard finger flanges. A new design could feature a more ergonomic, contoured grip or a "winged" flange to better accommodate users with different hand sizes or arthritis.</li>
                    </ul>
                </li>
                <li><span class="opportunity">Mechanism Miniaturization:</span>
                    <ul>
                        <li><strong>Idea 1:</strong> This design is for a standard syringe. A significant design challenge would be to adapt this constant-force "gated" mechanism for much smaller applications, like auto-injectors for biologics or ultra-low-volume syringes, where space is at a premium. This would require re-thinking the geometry of all components.</li>
                    </ul>
                </li>
            </ul>
        </div>
        
        <div class="section">
            <h2>6. Infringement Avoidance Strategy</h2>
            <p>To avoid infringing on this patent, a new design must not contain one or more of the essential elements of the independent claims. Let's analyze the broadest independent claim, Claim 1.</p>
            
            <h3>Deconstruction of Independent Claim 1:</h3>
            <p>A new design would likely infringe if it has ALL of the following elements:</p>
            <ol>
                <li>An automatically retracting safety needle assembly comprising:</li>
                <li><span class="claim-element">a housing</span>, with an <span class="claim-element">internal housing (IH)</span> and a base wall;</li>
                <li>a <span class="claim-element">moving sleeve (MOS)</span>, at least partially within the IH, with a flange wall, and is axially movable;</li>
                <li>a <span class="claim-element">biasing element (BE)</span> within the IH, supported between the base wall and the MOS flange wall, biasing the MOS proximally;</li>
                <li>a <span class="claim-element">syringe</span>, disposed in and movable axially within the IH, coupled to the MOS;</li>
                <li>an <span class="claim-element">activation fork (AF)</span>, partially disposed within the IH, comprising at least one <span class="claim-element">guiding arm</span>;</li>
                <li>The guiding arm is <span class="claim-element">coupled with the IH and the MOS</span> so as to <span class="claim-element">prevent proximal motion of the MOS</span> in the non-deployment state;</li>
                <li>Deployment involves advancing the plunger rod and the AF, until the guiding arm <span class="claim-element">allows proximal movement of the MOS</span>, causing retraction.</li>
                <li>The distal advancement of the plunger rod is <span class="claim-element">substantially constant</span> without an abrupt increase in resistive force.</li>
            </ol>

            <h3>"Design-Around" Strategies:</h3>
            
            <ul>
                <li><span class="risk">Design Around the "Activation Fork (AF)":</span> This is a key element.
                    <ul>
                        <li><strong>Strategy 1:</strong> Eliminate the fork. Create a trigger mechanism that is part of the plunger stopper itself. For example, as the stopper reaches the distal end of the syringe barrel, it could mechanically disengage a latch that holds the MOS, without needing a separate "fork" component extending alongside the syringe.</li>
                        <li><strong>Strategy 2:</strong> Change the nature of the trigger. Instead of a geometric alignment of a fork, use a pressure-based trigger. Once the plunger bottoms out, a momentary pressure spike could be used to rupture a small diaphragm or activate a pressure-sensitive latch, releasing the MOS. This would fundamentally change element #7 and #8.</li>
                    </ul>
                </li>
                <li><span class="risk">Design Around the "Moving Sleeve (MOS)":</span>
                    <ul>
                        <li><strong>Strategy 1:</strong> Invert the mechanism. Instead of the syringe/sleeve retracting into the housing, have a part of the *housing* (a safety shield) spring forward to cover the stationary needle. The plunger-end trigger could release this forward-moving shield instead of the backward-moving sleeve.</li>
                    </ul>
                </li>
                <li><span class="risk">Design Around the "Gating" Mechanism:</span> The patent describes the AF arm physically blocking the MOS.
                    <ul>
                        <li><strong>Strategy 1:</strong> Use a rotational release. The plunger's distal movement could cause a slight rotation of a component, which then unlocks the MOS. The patent's first embodiment (ROS) uses rotation *after* release, but a new design could use rotation *as the trigger*. For example, the plunger's final travel could engage a helical track, forcing a component to rotate and unlatch.</li>
                    </ul>
                </li>
            </ul>
        </div>
        
        <div class="section">
            <h2>7. Conclusion</h2>
            <p>US Patent 11,850,410 B2 presents a sophisticated and effective solution to a tangible problem in medical device usability and safety. Its core strength lies in the constant-force activation mechanism, which is a significant improvement over prior art.</p>
            <ul>
                <li><strong>For Understanding:</strong> The key is the "gated" release system. The Activation Fork acts as a gate, held closed during injection and opened only when the plunger reaches its final geometric position.</li>
                <li><strong>For New Designs:</strong> The most fertile ground for innovation lies in simplifying the part count (e.g., integrating the AF and plunger) and exploring fundamentally different trigger mechanisms (e.g., pressure-based, rotational, or inverting the motion so a shield moves forward).</li>
                <li><strong>For Infringement Avoidance:</strong> Focus on designing a system that does not use an "Activation Fork" as described, or one where the syringe/sleeve does not retract. Any design that achieves automatic retraction via a plunger-actuated release of a spring-loaded component risks falling within the scope of these claims, so the specific implementation of the trigger is paramount.</li>
            </ul>
        </div>

    </div>

    <footer>
        <p>This report is for informational and educational purposes only and does not constitute legal advice. Consult with a qualified patent attorney for legal opinions on patentability or freedom to operate.</p>
        <p>Analysis generated based on US Patent 11,850,410 B2.</p>
    </footer>

</body>
</html>